AMERGE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Naratriptan Hydrochloride.
| Product ID | 0173-0562_5b76fec2-b609-4a83-8276-412205c701f1 |
| NDC | 0173-0562 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AMERGE |
| Generic Name | Naratriptan Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1998-02-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020763 |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | NARATRIPTAN HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/1 |
| Pharm Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1998-02-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020763 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-02-26 |
| Marketing Category | NDA |
| Application Number | NDA020763 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-10-31 |
| Marketing End Date | 2013-03-04 |
| Ingredient | Strength |
|---|---|
| NARATRIPTAN HYDROCHLORIDE | 2.5 mg/1 |
| SPL SET ID: | 13f4a8ec-75a3-4c51-b3bc-6244f3c79e95 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0173-0561 | AMERGE | naratriptan hydrochloride |
| 0173-0562 | AMERGE | naratriptan hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AMERGE 98069353 not registered Live/Pending |
Amerge, LLC 2023-07-03 |
![]() AMERGE 78027114 2480159 Dead/Cancelled |
Amerge Corporation 2000-09-21 |
![]() AMERGE 75165466 2170207 Live/Registered |
GLAXO GROUP LIMITED 1996-09-13 |